[Stereotactic radiotherapy for localized primary lung tumours of stage T1-T2]

P Boisselier; A Coutte; E Martin; Y Pointreau

doi:10.1016/j.canrad.2022.07.005

[Stereotactic radiotherapy for localized primary lung tumours of stage T1-T2]

Cancer Radiother. 2022 Oct;26(6-7):755-759. doi: 10.1016/j.canrad.2022.07.005. Epub 2022 Sep 6.

[Article in French]

Authors

P Boisselier¹, A Coutte², E Martin³, Y Pointreau⁴

Affiliations

¹ Service de radiothérapie oncologie, Institut du Cancer de Montpellier (ICM) - Val d'Aurelle, Parc Euromédecine, 208, avenue des Apothicaires, 34090 Montpellier, France. Electronic address: [email protected].
² Service de radiothérapie oncologie, CHU Amiens Picardie, 1, rond-point du Professeur Christian Cabrol, 80054 Amiens, France.
³ Département de radiothérapie, centre Georges-François Leclerc, 1, rue du Professeur-Marion, 21079 Dijon, France.
⁴ Institut inter-régionaL de cancérologie (ILC) - centre Jean-Bernard, 9, rue Beauverger, 72000 Le Mans, France.

PMID: 36075829
DOI: 10.1016/j.canrad.2022.07.005

Abstract

The historical treatment for stage I non-small cell lung cancer is surgical. Parenchymal amputation is not always possible due to cardiopulmonary comorbidities and stereotactic radiotherapy is one of the alternatives to an invasive procedure. The excellent results observed for inoperable tumors raised the question of this treatment in operable patients. This article presents the data in these two situations and the future perspectives.

Keywords: Cancer du poumon; Early stage; Lung cancer; Radiothérapie stéréotaxique; Stade localisé; Stereotactic body radiotherapy.

Publication types

Review

MeSH terms

Carcinoma, Non-Small-Cell Lung* / pathology
Carcinoma, Non-Small-Cell Lung* / radiotherapy
Carcinoma, Non-Small-Cell Lung* / surgery
Humans
Lung / pathology
Lung Neoplasms* / pathology
Lung Neoplasms* / radiotherapy
Lung Neoplasms* / surgery
Neoplasm Staging
Radiosurgery* / methods
Treatment Outcome